软胶囊市场：按产品类型、按原产地类型、按应用、按最终用户、按地区

软胶囊的全球市场规模预计将从 2023 年的 69.339 亿美元增至 2030 年的 107.406 亿美元，预测期内年复合成长率(CAGR)为 6.4%。

图 1. 2023 年软胶囊全球市场占有率(%)（按地区）

软胶囊，也称为软胶囊，是一种由软明胶基材料製成的胶囊，内含液体或半固体填充物。与传统硬胶囊相比，填充材和明胶壳具有不同的优点。软胶囊壳比硬胶囊更薄、更弹性，使其能够以更小的剂型提供更多的填充量，受到消费者的青睐。与硬胶囊相比，明胶材料也加速了壳的溶解，导致摄入后的填充物吸收更快。

软胶囊有两种主要类型。第一种类型被包含活性填充剂成分的单一软明胶壳包围。第二种是双壁的，具有防止填充洩漏的内密封层和提供结构完整性的外支撑层。软胶囊能够容纳液体、固体，甚至干燥或糊状填充物，开启了硬胶囊以外的配方可能性。然而，与硬胶囊相比，生产软胶囊需要专门的设备和专业知识，这会增加生产成本。明胶壳的稳定性也低于硬胶囊壳，使其更容易受到热、湿气和不当储存条件的影响。

市场动态：.

全球软胶囊市场主要是由于全球心血管疾病的盛行率不断上升，这增加了软胶囊的消费和需求。动脉粥状硬化和冠状动脉疾病等各种心血管疾病已成为主要的医疗负担，特别是在人口老化和生活方式改变的已开发国家。就心臟疾病而言，心血管疾病已成为死亡和长期残疾的主要原因。例如，2023 年 5 月 15 日，美国疾病管制与预防中心发布的一份美国美国、女性以及大多数种族和民族人民的首要死因；1 10人死于心血管疾病。

此外，2022年11月，加拿大公共卫生局发布的报告发现，心臟病是加拿大第二大死因，每年夺走超过5万人的生命。

本研究的主要特点

• 该报告对全球软胶囊市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
• 它还阐明了各个细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
• 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球软胶囊市场的主要企业。
• 该报告的见解使行销人员和公司负责人能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球软胶囊市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 相关人员可以透过分析全球软胶囊市场时所使用的各种策略矩阵来促进决策。

目录

第一章 研究目的与前提

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

• 市场动态
• 主要亮点
• 监管场景
• 最近的趋势
• PEST分析
• 波特的分析
• 合併、收购和合作

第四章全球软胶囊市场－冠状病毒(COVID-19) 大流行的影响

• 新型冠状病毒感染疾病（COVID-19）的流行病学
• 供需面分析
• 经济影响

第五章全球软胶囊市场，依产品类型，2018-2030

• 明胶软胶囊
• 非明胶软胶囊

第六章全球软胶囊市场，依原产地类型，2018-2030

• 动物起源
• 非动物的

第七章全球软胶囊市场，依应用分类，2018-2030

• 发炎药
• 抗生素
• 心血管药物
• 保健补充食品
• 其他的

第 8 章全球软胶囊市场，按最终用户划分，2018-2030 年

• 製药公司
• 契约製造组织
• 营养保健品公司
• 其他的

第9章2018-2030年全球软胶囊市场（按地区）

• 北美洲
• 美国
• 加拿大
• 欧洲
• 德国
• 英国
• 西班牙
• 法国
• 义大利
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 中国
• 印度
• 日本
• 澳洲
• 韩国
• ASEAN
• 其他亚太地区
• 拉丁美洲
• 巴西
• 阿根廷
• 墨西哥
• 其他拉丁美洲
• 中东
• 海湾合作委员会国家
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中部非洲
• 南非

第10章竞争形势

• 公司简介
  • Catalent, Inc.
  • Aenova Group GmbH
  • Sirio Pharma Company Ltd
  • Captek Softgel International Inc.
  • Elnova Pharma
  • Fuji Capsule Co., Ltd.
  • Capsugel, EuroCaps Ltd
  • Guangdong Yichao Biological Co., Ltd.
  • Hunan ER-KANG Pharmaceutical Co Ltd
  • KD Pharma Group
  • United Laboratories
  • Soft Gel Technologies, Inc.
  • Windzor Pharma Ltd
  • ZYUS Life Sciences Inc.
  • EuroCaps

第11章 章节

• 参考
• 调查方法
• 关于出版商

Global softgel capsule market size is expected to reach US$ 10,740.6 Mn by 2030, from US$ 6,933.9 Mn in 2023, exhibiting a compound annual growth rate (CAGR) of 6.4% during the forecast period.

Figure 1. Global Softgel Capsule Market Share (%), By Region, 2023

Softgel capsules which is also known as softgels, are a type of capsule made of a soft, gelatin-based material that envelops a liquid or semi-solid fill. The fill material and gelatin shell offer different advantages over traditional hard capsules. Softgel shells are thinner and more flexible than hard capsules, thereby allowing more fill to be delivered in a smaller dosage form which is appreciated by consumers. The gelatin material also permits faster dissolution of the shell, thus making the fill available for absorption more quickly after ingestion compared to hard capsules.

There are two main types of softgel capsules. The first type is surrounded by a single soft gelatin shell which contains the active fill ingredient. The second type has a dual-layered construction with an inner sealing layer preventing leakage of the fill and an outer support layer providing structural integrity. Softgels are capable of holding liquid, semi-solid and even dry or paste-like fills which opens up formulation possibilities beyond what is offered by hard capsules. However, softgel manufacturing requires specialized equipment and expertise as compared to hard capsules which can increase production costs. Their gelatin-based shell is also less stable than hard capsule shells making them more vulnerable to heat, moisture and improper storage conditions.

Market Dynamics:

Global softgel capsule market is mainly driven by the increasing prevalence of cardiovascular diseases across the world, thus leading to increasing consumption and demand of softgel capsules. Various cardiovascular diseases such as atherosclerosis, coronary artery diseases, and others have become major healthcare burdens, especially in developed nations with aging populations and lifestyle changes. As cardiac associations, cardiovascular diseases have emerged as the leading cause of mortality and long-term disabilities. For instance, on May 15, 2023, according to the report published by the Centers for Disease Control and Prevention, heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the U.S., while one person dies every 33 seconds in the U.S. from cardiovascular disease.

Furthermore, in November 2022, according to the report published by the Public Health Agency in Canada, heart disease is the second leading cause of death in Canada, claiming more than 50,000 lives each year.

Key features of the study:

• This report provides in-depth analysis of the global softgel capsule market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global softgel capsule market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Catalent, Inc., Aenova Group GmbH, Sirio Pharma Company Ltd, Captek Softgel International Inc., Elnova Pharma, Fuji Capsule Co., Ltd., Capsugel, EuroCaps Ltd, Guangdong Yichao Biological Co., Ltd., Hunan ER-KANG Pharmaceutical Co Ltd, KD Pharma Group, United Laboratories, Soft Gel Technologies, Inc., Windzor Pharma Ltd , ZYUS Life Sciences Inc. and EuroCaps
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global softgel capsule market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global softgel capsule market

Detailed Segmentation:

• Global Softgel Capsule Market, By Product Type
  • Gelatin Softgel Capsule
  • Non-gelatin Softgel Capsule
• Global Softgel Capsule Market, By Source Type
  • Animal-based
  • Non-animal-based
• Global Softgel Capsule Market, By Application
  • Anti-inflammatory Drugs
  • Antibiotic Drugs
  • Cardiovascular Drugs
  • Health Supplements
  • Others
• Global Softgel Capsule Market, By End User
  • Pharmaceutical Companies
  • Contract Manufacturing Organizations
  • Neutraceuticals Companies
  • Others
• Global Softgel Capsule Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Top Companies in the Global Softgel Capsule Market:
  • Catalent, Inc.
  • Aenova Group GmbH
  • Sirio Pharma Company Ltd
  • Captek Softgel International Inc.
  • Elnova Pharma
  • Fuji Capsule Co., Ltd.
  • Capsugel, EuroCaps Ltd
  • Guangdong Yichao Biological Co., Ltd.
  • Hunan ER-KANG Pharmaceutical Co Ltd
  • KD Pharma Group
  • United Laboratories
  • Soft Gel Technologies, Inc.
  • Windzor Pharma Ltd
  • ZYUS Life Sciences Inc.
  • EuroCaps

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Softgel Capsule Market, By Product Type
  • Global Softgel Capsule Market, By Source Type
  • Global Softgel Capsule Market, By Application
  • Global Softgel Capsule Market, By End User
  • Global Softgel Capsule Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rising global nutraceuticals industry
  • High production cost associated with softgel capsules
  • Emerging markets in Asia Pacific and Latin America
• Key Highlights
• Regulatory Scenario
• Recent Trends
• PEST Analysis
• PORTER's Analysis
• Mergers, Acquisitions, and Collaborations

4. Global Softgel Capsule Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Softgel Capsule Market, By Product Type, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Gelatin Softgel Capsule
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Non-gelatin Softgel Capsule
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Global Softgel Capsule Market, By Source Type, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Animal-based
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Non-animal-based
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

7. Global Softgel Capsule Market, By Application, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Anti-inflammatory Drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Antibiotic Drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Cardiovascular Drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Health Supplements
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

8. Global Softgel Capsule Market, By End User, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Pharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Contract Manufacturing Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Neutraceuticals Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

9. Global Softgel Capsule Market, By Region, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Region, 2019 -2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Mn)
• North Africa
• Central Africa
• South Africa

10. Competitive Landscape

• Company Profile
  • Catalent, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Aenova Group GmbH
  • Sirio Pharma Company Ltd
  • Captek Softgel International Inc.
  • Elnova Pharma
  • Fuji Capsule Co., Ltd.
  • Capsugel, EuroCaps Ltd
  • Guangdong Yichao Biological Co., Ltd.
  • Hunan ER-KANG Pharmaceutical Co Ltd
  • KD Pharma Group
  • United Laboratories
  • Soft Gel Technologies, Inc.
  • Windzor Pharma Ltd
  • ZYUS Life Sciences Inc.
  • EuroCaps
• Analyst Views

11. Section

• References
• Research Methodology
• About us